Delivery Order SPE2DB22D1106-SPE2DB25FFJD8
Award Date 9/12/25
Potential Completion Date 9/15/25
Potential Value $5.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Ganirelix Acetate 250 micrograms/0.5 milliliters in 0.5-milliliter units, with a ceiling value of $3,202.64 and an ultimate completion date of August 22, 2025. This non-set-aside contract represents a routine pharmaceutical procurement executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Ganirelix Acetate 250 mcg/0.5 mL injection vials, with a contract ceiling value of $7,448.00. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The work is to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ganirelix Acetate 250 mcg/0.5 mL injectable medication, valued at $6,739.56 with a firm fixed price arrangement. The award was made on August 27, 2025, with an ultimate completion date of August 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,735.56 Firm Fixed Price delivery order is for the drug Ganirelix Acetate 250 MCG/0.5 ML 0.5ML, with a completion date of January 7, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,186,420 units of Ganirelix Acetate 250 mcg/0.5 mL. The $4,320.00 order has a completion date of December 28, 2023. Amerisourcebergen Drug Corp is a prime contractor that has previously received numerous federal awards from DLA Troop Support Medical to supply pharmaceuticals, medical supplies, and...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,058.04, is for the delivery of the drug Ganirelix Acetate 250 MCG/0.5 ML 0.5ML. It has an ultimate completion date of December 11, 2024. This contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This is a $2,979.20 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Ganirelix Acetate, a specialty medication used for medical treatments. The contract has a completion date of February 6, 2025 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a $21,950 firm fixed-price delivery order to AmerisourceBergen Drug Corp for GONAL-F RFF Redi-Ject 900 Unit 1.44ML, a pharmaceutical product used in fertility treatment. The award was made on September 11, 2025, with an ultimate completion date of September 12, 2025, and is not designated as a set-aside contract. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- AmerisourceBergen Drug Corp was awarded a delivery order contract valued at $16,462.50 by the Defense Logistics Agency (DLA) Medical Supply Chain on September 8, 2025, for the supply of GONAL-F RFF REDI-JECT 900 Unit 1.44ML, a pharmaceutical product. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award selection. Performance will be executed from the company's corporate office location in Conshohocken, Pennsylvania, with an...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $38,412.50 for GONAL-F RFF Redi-Ject 900 Unit 1.44ML, a pharmaceutical product, with an ultimate completion date of August 28, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be...